Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125. [electronic resource]
- Clinical chemistry Aug 2002
- 1364-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-9147
Adult Aged Antineoplastic Agents, Phytogenic--therapeutic use CA-125 Antigen--blood Female Humans Middle Aged Neoplasm Recurrence, Local Ovarian Neoplasms--diagnosis Paclitaxel--therapeutic use Prognosis Prospective Studies Reference Values